Global Reach Motiva Implants are approved for commercial distribution in over 70 countries via exclusive distributors or a direct salesforce, indicating a broad addressable market and established channel networks. This presents opportunities for sales enablement, distributor training, regional marketing support, and coordinated product launches to accelerate adoption and revenue growth.

US IDE Opportunity FDA IDE approval to conduct Motiva clinical trials in the United States creates pathways for U.S. hospital and physician partnerships, clinical programs, and data generation that can support broader adoption and potential reimbursement discussions when scale aligns with payer expectations.

Latin America Expansion Preservé launch in Brazil marks the first country in a global rollout, signaling a tangible expansion plan in Latin America and an opportunity to build regional distributor networks, local marketing, and training to capture early-adopter clinics.

IP Landscape Ongoing patent and IP actions in Europe and other regions highlight competitive dynamics and risk, underscoring the need for differentiation based on safety and outcomes, while presenting potential avenues for licensing, partnerships, or co-development with selective partners.

Scale and Capacity Two FDA-compliant facilities in Costa Rica provide robust manufacturing capacity and supply reliability to support large multi-country procurements, backed by a sizable workforce and a modern tech stack including SAP R/3 for integrated ordering, forecasting, and post-sale services.